All In Biotech

Drug Trial Radar · NCT00005577

Gemcitabine in Treating Children With Refractory Solid Tumors

A PEDIATRIC PHASE I STUDY OF GEMCITABINE (NSC# 613327) IN SOLID TUMORS

Last checked: Nov 20, 2026Latest source record: Feb 5, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Aug 1996

Primary completion

Sep 2002

Sponsor

Sponsor type
NIH
First posted
Apr 2, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 year, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase I trial to study the effectiveness of gemcitabine in treating children who have refractory solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Conditions

  • Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

  • gemcitabine hydrochlorideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

23 sites in 2 countries. Site status is shown where the registry gives one.

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Jonsson Comprehensive Cancer Center, UCLA

    Los Angeles, California

  • Cancer Center and Beckman Research Institute, City of Hope

    Los Angeles, California

  • Children's Hospital of Orange County

    Orange, California

  • UCSF Cancer Center and Cancer Research Institute

    San Francisco, California

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Indiana University Cancer Center

    Indianapolis, Indiana

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan

  • University of Minnesota Cancer Center

    Minneapolis, Minnesota

  • Mayo Clinic Cancer Center

    Rochester, Minnesota

  • Children's Mercy Hospital

    Kansas City, Missouri

  • NYU School of Medicine's Kaplan Comprehensive Cancer Center

    New York, New York

  • Memorial Sloan-Kettering Cancer Center

    New York, New York

  • Herbert Irving Comprehensive Cancer Center

    New York, New York

  • Children's Hospital Medical Center - Cincinnati

    Cincinnati, Ohio

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee

  • University of Texas - MD Anderson Cancer Center

    Houston, Texas

  • Huntsman Cancer Institute

    Salt Lake City, Utah

  • Children's Hospital and Regional Medical Center - Seattle

    Seattle, Washington

  • University of Wisconsin Comprehensive Cancer Center

    Madison, Wisconsin

  • Princess Margaret Hospital for Children

    Perth, Western Australia, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.